Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 6/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.44 |
| ▸ | MIF | P14174 | 4/20 | 0.44 |
| ▸ | BACH1 | O14867 | 1/20 | 0.44 |
| ▸ | MAFK | O60675 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 7/20 | 0.34 |
| ▸ | XPO1 | O14980 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14489602 | 0.75 | — | — | |
| SCHEMBL2040306 | 0.72 | — | — | |
| SCHEMBL25333148 | 0.70 | — | — | |
| SCHEMBL691779 | 0.70 | — | — | |
| Ethane SCHEMBL1821048 | 0.68 | KEAP1 (0.40) | KEAP1NFE2L2MIFBACH1MAFK | |
| SCHEMBL9531670 | 0.67 | — | — | |
| SCHEMBL25332582 | 0.67 | — | — | |
| SCHEMBL362346 | 0.65 | KEAP1 (0.50) | KEAP1NFE2L2MIFBACH1MAFK | |
| SCHEMBL1364810 | 0.65 | — | — | |
| SCHEMBL14293938 | 0.64 | HSD17B10 (0.37) | KEAP1NFE2L2MIFBACH1MAFK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120208879-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | GAVISH-GALILEE BIO APPLICATIONS LTD. (IL) | 2012-08-16 | — | — | US | claimed |
| US-20080044497-A1 | Methods and Pharmaceutical Compositions Useful for Treating Psoriasis | S.U.L.V.E. LTD. (IL) | 2008-02-21 | — | — | US | claimed |
| EP-1841320-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. Ltd. (IL) | 2007-10-10 | — | — | EP | claimed |
| WO-2006075330-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. LTD. (IL) | 2006-07-20 | — | — | WO | claimed |
| WO-2020021544-A1 | CANNABIDIOL AND METHYLTHIO-BUTYL-ISOTHIOCYANATE FOR TREATING INFLAMMATORY DISEASES | BOL PHARMA LTD. (IL) | 2020-01-30 | — | — | WO | disclosed |
| US-20120208879-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | GAVISH-GALILEE BIO APPLICATIONS LTD. (IL) | 2012-08-16 | — | — | US | disclosed |
| US-8158161-B2 | Methods and pharmaceutical compositions useful for treating psoriasis | S.U.L.V.E. LTD. (IL) | 2012-04-17 | — | — | US | disclosed |
| US-20080044497-A1 | Methods and Pharmaceutical Compositions Useful for Treating Psoriasis | S.U.L.V.E. LTD. (IL) | 2008-02-21 | — | — | US | disclosed |
| EP-1841320-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. Ltd. (IL) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006075330-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING PSORIASIS | S.U.L.V.E. LTD. (IL) | 2006-07-20 | — | — | WO | disclosed |